当前位置:首页 - 行情中心 - 诚达药业(301201) - 财务分析

诚达药业

(301201)

  

流通市值:16.96亿  总市值:30.09亿
流通股本:8719.38万   总股本:1.55亿

诚达药业(301201)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.41亿元,每股收益0.27元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益223300.84万元,未分配利润38326.42万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产239538.86万元,负债16238.02万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入243,768,662.64164,012,180.77100,889,692.8414,301,764.07
营业总成本235,403,173.38164,252,771.6988,945,893.49351,493,181.66
营业利润44,704,496.8727,588,214.0922,983,798.7107,799,127.62
利润总额42,436,915.226,256,508.2422,037,234.52104,249,971.22
净利润40,536,262.3125,207,819.7918,726,286.1991,102,027.9
其他综合收益----
综合收益总额40,536,262.3125,207,819.7918,726,286.1991,102,027.9
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计1,463,203,712.551,518,058,580.331,568,715,897.51,642,866,608.15
非流动资产合计932,184,859.53888,790,446.94835,033,356.99812,458,410
资产总计2,395,388,572.082,406,849,027.272,403,749,254.492,455,325,018.15
流动负债合计157,737,025.04152,895,149.2153,321,342.18171,532,610.89
非流动负债合计4,643,128.424,729,659.644,525,200.024,870,448.48
负债合计162,380,153.46157,624,808.84157,846,542.2176,403,059.37
归属于母公司股东权益合计2,230,686,764.42,247,393,014.172,244,022,755.562,277,123,782.24
股东权益合计2,233,008,418.622,249,224,218.432,245,902,712.292,278,921,958.78
负债和股东权益合计2,395,388,572.082,406,849,027.272,403,749,254.492,455,325,018.15
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计350,488,064.73227,419,748.44142,615,023.64482,634,835.09
经营活动现金流出小计292,565,017.91180,704,770.41104,531,208.38290,562,447.45
经营活动产生的现金流量净额57,923,046.8246,714,978.0338,083,815.26192,072,387.64
投资活动现金流入小计998,246,472.1182,204,590.779,388,395.891,319,060,690.21
投资活动现金流出小计1,857,376,963.31497,216,926.58156,667,041.02724,669,555.47
投资活动产生的现金流量净额-859,130,491.2-415,012,335.81-147,278,645.13594,391,134.74
筹资活动现金流入小计380,000---
筹资活动现金流出小计86,172,824.4155,290,464.5651,941,867.129,008,842
筹资活动产生的现金流量净额-85,792,824.41-55,290,464.56-51,941,867.1-29,008,842
汇率变动对现金及现金等价物的影响1,807,603.451,658,435.2199,253.8804,058.26
现金及现金等价物净增加额-885,192,665.34-421,929,387.13-161,037,443.17758,258,738.64
期末现金及现金等价物余额477,496,249.44940,759,527.651,202,901,471.611,362,688,914.78
TOP↑